<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Sudden unexpected <z:hpo ids='HP_0011420'>death</z:hpo> in <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SUDEP</z:e>) is the most common <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e>-related cause of <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>While the precise pathophysiological mechanisms underlying <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SUDEP</z:e> are still uncertain, impaired cardiac function including <z:hpo ids='HP_0001250'>seizure</z:hpo>-induced <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> has received increased attention </plain></SENT>
<SENT sid="2" pm="."><plain>In addition, the potential role of <z:chebi fb="0" ids="35623">antiepileptic</z:chebi> drugs has been suggested </plain></SENT>
<SENT sid="3" pm="."><plain>While the preponderance of clinical data would suggest that use of most <z:chebi fb="0" ids="35623">antiepileptic</z:chebi> drugs does not pose excessive additional risk of QT prolongation, available data also do not provide sufficient evidence that these drugs are entirely free of risk in <z:hpo ids='HP_0000001'>all</z:hpo> patients </plain></SENT>
<SENT sid="4" pm="."><plain>In particular, the potential for these medications, either alone or in combination, to prolong the QT interval should be considered </plain></SENT>
<SENT sid="5" pm="."><plain>This review will discuss mechanisms for drug-induced QT prolongation and its relationship to potentially fatal <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> such as <z:hpo ids='HP_0001664'>torsades de pointes</z:hpo> </plain></SENT>
</text></document>